Cite
TCT-493 The Clinical Utility of High-Sensitive Troponin T to Predict Infarct Size, Left Ventricular Function and Adverse Outcome in Patients with First ST Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
MLA
Matthijs A. Velders, et al. “TCT-493 The Clinical Utility of High-Sensitive Troponin T to Predict Infarct Size, Left Ventricular Function and Adverse Outcome in Patients with First ST Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.” Journal of the American College of Cardiology, no. 17, p. B143. EBSCOhost, https://doi.org/10.1016/j.jacc.2012.08.525. Accessed 17 Dec. 2024.
APA
Matthijs A. Velders, S. le Cessie, M.J. Schalij, T.A.N. Ahmed, Helèn Boden, Christa M. Cobbaert, Marianne Bootsma, A. van der Laarse, Georgette E. Hoogslag, & B.L. van der Hoeven. (n.d.). TCT-493 The Clinical Utility of High-Sensitive Troponin T to Predict Infarct Size, Left Ventricular Function and Adverse Outcome in Patients with First ST Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention. Journal of the American College of Cardiology, 17, B143. https://doi.org/10.1016/j.jacc.2012.08.525
Chicago
Matthijs A. Velders, S. le Cessie, M.J. Schalij, T.A.N. Ahmed, Helèn Boden, Christa M. Cobbaert, Marianne Bootsma, A. van der Laarse, Georgette E. Hoogslag, and B.L. van der Hoeven. 2024. “TCT-493 The Clinical Utility of High-Sensitive Troponin T to Predict Infarct Size, Left Ventricular Function and Adverse Outcome in Patients with First ST Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.” Journal of the American College of Cardiology, no. 17: B143. Accessed December 17. doi:10.1016/j.jacc.2012.08.525.